Dr. Jain leads commercial strategy and partnerships across providers, payers, life sciences and the startup ecosystem at Hippocratic AI, a safety-focused generative AI company building large language model solutions tuned specifically for the healthcare industry. Dr. Jain joined the company in June 2025, bringing a rare combination of clinical training, investment experience and product leadership to her role. Before Hippocratic AI, she led healthcare investing at Tarsadia Investments and Cota Capital, and served as a product leader at a healthcare AI startup. She was trained as a primary care physician, grounding her commercial and strategic work in a firsthand understanding of how care is delivered and where technology can meaningfully expand access. In direct alignment with Hippocratic AI’s founding principle of building technology committed to doing no harm, Dr. Jain believes generative AI has the potential to dramatically increase healthcare access globally, if built and tested responsibly.
